Liver transplantation for chronic hepatitis C: Long-term results, role of antiviral therapy, and outcome of retransplantation

Current Opinion in Organ Transplantation

Volumn 6, Issue 2, 2001, Pages 114-119

  Powers, Jason J ^b   Shumaker, Douglas A ^b   Rosen, Hugo R ^a,b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; INTERFERON; RIBAVIRIN;

ALLOGRAFT; ARTICLE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LEUKOPENIA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; RECURRENT INFECTION; REOPERATION; SURVIVAL; TREATMENT INDICATION; TREATMENT OUTCOME; VIREMIA;

EID: 0034954691     PISSN: 10872418     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075200-200106000-00003     Document Type: Article

References (21)

1. Recovery, persistence, and sequelae in hepatitis C virus infection: A perspective on long-term outcome
2. HCV-related fibrosis progression following liver transplantation: Increase in recent years
3. Hepatitis C after liver transplantation
4. Retransplantation for hepatitis C: Implications of different policies
5. Long-term outcome of hepatitis C infection after liver transplantation
6. High incidence of allograft cirrhosis in hepatitis C virus genotype 1B infection following transplantation: Relation with rejection episodes
7. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation
8. Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate
9. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: Results of the National Institute of Diabetes and Digestive and Kidney Disease Liver Transplantation Database
10. Association of multispecific CD4+ response to hepatitis C and severity of recurrence after liver transplantation
11. The humoral immune response to hepatitis C following liver transplantation: Assessment of a new recombinant immunoblot assay
12. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation
13. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
14. Posttransplantation prevention and treatment of recurrent hepatitis C
15. Treatment of progressive hepatitis C recurrence following liver transplantation with combination interferon plus ribivirin
16. Retransplantation for recurrent HCV
17. Clinical and histologic patterns in early graft failure due to recurrent hepatitis C infection after liver transplantation
18. Recurrent hepatitis C after liver transplantation
19. Graft loss following liver transplantation in patients with chronic hepatitis C
20. Orthotopic liver transplantation for hepatitis C: Outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single center experience
21. Hepatitis C virus infection in patients undergoing liver retransplantation